000739.SZ
普洛药业
SZSE · Healthcare · C 制造业 · CN
CNY 19.71
−4.87%Margins
Gross margin
27.8%
EBITDA margin
18.3%
EBIT margin
11.3%
Net margin
9.4%
FCF margin
10.4%
13.6%
Return on equity
7.3%
Return on assets
13.2%
Return on invested capital
0.77x
Asset turnover
CNY 1.4B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026